Laura Lande-Diner
, PhD, Managing Partner, Jefferson Life Sciences
Laura Lande-Diner, PhD, is a scientist, company builder, and investor dedicated to advancing innovative therapeutics.
An experienced biotech entrepreneur and C-suite executive, Laura brings deep expertise in company creation, fundraising, and operational leadership. She has a proven track record of co-founding and scaling life sciences companies, driving corporate and clinical strategy, and securing top-tier venture funding. She excels at partnering with scientific founders and executive teams to shape robust IP portfolios, align product pipelines with strategic objectives, and navigate complex regulatory landscapes. Her strengths in building investor networks and leading business development initiatives have resulted in successful strategic partnerships and long-term value creation.
Laura is the Managing Partner at Jefferson Life Sciences, an early-stage life sciences investment fund focused on backing groundbreaking approaches in human biology and medicine, and part of Jefferson River Capital. Prior to Jefferson Life Sciences, she was a founding executive at Satellite Bio, where she served as Chief Business Officer and later as President. Before Satellite, she was a founding team member at Valo Health, where she designed and led the company’s early data strategy and executed four foundational business development partnerships within 18 months of launch.
Laura earned her PhD in Epigenetics and Molecular Biology from the Hebrew University of Jerusalem Medical School and conducted her postdoctoral research in Circadian Biology at Harvard Medical School, where she later served as an Instructor in Neurobiology. She is a named inventor on numerous patents and applications and has authored multiple peer-reviewed publications. In 2017, she was named one of the 100 Most Inspiring People in the life sciences industry by PharmaVOICE.
